Two Teradyne insiders sold a combined 4,800 shares at $337.83 apiece on the same day, worth about $1.62 million.
Two insiders at Teradyne (TER) sold shares of the semiconductor test equipment maker on 15 September 2026, according to Form 4 filings submitted to the Securities and Exchange Commission. The combined open-market value of the transactions came to roughly $1,621,584, all executed at $337.83 per share.
Tadaa Technology will supply the AI backbone for a 1,000-acre solar farm feeding a data centre under a 25-year power arrangement, targeting $7.3M in annual revenue.
Alpha Compute has signed definitive agreements for Utica and Marcellus acreage with more than 75 wells, and plans to build a data center on the site.
Palisade Bio can start the Phase 2 ASCENTRA-CD trial of its oral PDE4 prodrug, with first dosing targeted for Q1 2027 and a primary readout in Q1 2028.
VERSATILE-002 results for PDS0101 plus pembrolizumab show 39.3 months median overall survival in checkpoint-inhibitor-naive HPV16-positive head and neck cancer.
